- Scrip Originals
Brought to you by
Gilead pays $65mm cash to buy EpiTherapeutics
02 Oct 2020
Gilead Sciences Inc. paid $65mm cash to acquire privately held epigenetics company EpiTherapeutics APS.
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com